Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -15.89x is 73% above its 1-year average of -59.50x, near the high end of its 1-year range (-103.11x–-15.89x).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-15.89x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-149.24%
vs the sector median at left
Hyperfine, Inc.
Market Cap
$73.27M
Interest Coverage Ratio
-15.89x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$72.83M
Interest Coverage Ratio
N/A
TTM Avg
933.58x
3Y Avg
933.58x
5Y Avg
933.58x
Market Cap
$72.32M
Interest Coverage Ratio
-1.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$75.18M
Interest Coverage Ratio
-17.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$71.23M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$70.63M
Interest Coverage Ratio
-1174.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$75.95M
Interest Coverage Ratio
-1.08x
TTM Avg
0.90x
3Y Avg
0.90x
5Y Avg
0.90x
Market Cap
$76.74M
Interest Coverage Ratio
-4.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$69.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hyperfine, Inc. (HYPR) | $73.27M | -15.89x | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | N/A | 933.58x | 933.58x | 933.58x |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.32M | -1.54x | N/A | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $75.18M | -17.01x | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $71.23M | N/A | N/A | N/A | N/A |
| Tiziana Life Sciences Ltd (TLSA)vs › | $70.63M | -1174.00x | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $75.95M | -1.08x | 0.90x | 0.90x | 0.90x |
| Outset Medical, Inc. (OM)vs › | $76.74M | -4.78x | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $69.61M | N/A | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | -23.23x | N/A | N/A | N/A |
Interest Coverage
-15.9x
Debt/Equity
0.36
Current Ratio
6.15
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -15.89x |
| 2026-03-31 | -103.11x |
